logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Gabriel N. Hortobágyi

md anderson cancer center
H指数:187
被引数:13.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007)

复发评分基因组成分与RxPONDER试验（SWOG S1007）中的结果

JNCI: Journal of the National Cancer Institute
IF0
2026-07-150
PRE
Yara Abdou, MD, MSCR; Jess Hoag, PhD; William E Barlow, PhD; Kathy S Albain, MD; Julie R Gralow, MD; Funda Meric-Bernstam, MD; Daniel F Hayes, MD; Nancy U Lin, MD; Edith A Perez, MD; Lori J Goldstein, MD; Stephen K L Chia, MD; Sukhbinder Dhesy-Thind, MD; Priya Rastogi, MD; Anne F Schott, MD; Jennifer Racz, MD; Frederick L Baehner, MD; Debasish Tripathy, MD; Gabriel N Hortobagyi, MD; Lajos Pusztai, MD, DPhil; Priyanka Sharma, MD; Kevin Kalinsky, MD
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival☆

HR阳性/HER2阴性早期乳腺癌患者的辅助瑞博西lib联合非甾体类芳香化酶抑制剂治疗：NATALEE试验5年随访的有效性结局及更新后的总生存期☆

ESMO Open
IF8.3
2025-10-170
OAAI
J. Crown; D. Stroyakovskii; D.A. Yardley; C.-S. Huang; P.A. Fasching; A. Bardia; S. Chia; S.-A. Im; M. Martin; B. Xu; C.H. Barrios; M. Untch; R. Moroose; S.A. Hurvitz; G.N. Hortobagyi; D.J. Slamon; F. Visco; G. Spera; J.P. Zarate; D. Halligan; Z. Li; S. Loi
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial

一项III期临床试验，比较在激素受体阳性/人表皮生长因子受体2阴性早期乳腺癌患者中，辅助瑞博西尼联合内分泌疗法与单独内分泌疗法的效果：NATALEE试验的最终浸润性疾病无进展生存结果

ANNALS OF ONCOLOGY
IF65.4
2025-02-017
PRE
Hortobagyi, G. N.; Lacko, A.; Sohn, J.; Cruz, F.; Borrego, M. Ruiz; Manikhas, A.; Park, Y. Hee; Stroyakovskiy, D.; Hurvitz, S.; Barrios, C.; Untch, M.; Moroose, R.; Yardley, D. A.; Visco, F.; Chia, S.; Huang, C. -s.; Fasching, P. A.; Parnizari, F.; Crown, J.; Zarate, J. P.; Bardia, A.; Loi, S.; Li, Z.; Martin, M.; Xu, B.; Im, S. -a.; Waters, S.; Chakravartty, A.; Slamon, D.
Ribociclib plus Endocrine Therapy in Early Breast Cancer
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2024-03-2156
PRE
Slamon, Dennis; Lipatov, Oleg; Nowecki, Zbigniew; McAndrew, Nicholas; Kukielka-Budny, Bozena; Stroyakovskiy, Daniil; Yardley, Denise A.; Huang, Chiun-Sheng; Fasching, Peter A.; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Ruiz-Borrego, Manuel; Loi, Sherene; Xu, Binghe; Hurvitz, Sara; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Afenjar, Karen; Fresco, Rodrigo; Severin, Irene; Ji, Yan; Ghaznawi, Farhat; Li, Zheng; Zarate, Juan P.; Chakravartty, Arunava; Taran, Tetiana; Hortobagyi, Gabriel
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique

管理与alpelisib相关的高血糖和皮疹: 使用Delphi技术的专家共识建议

NPJ BREAST CANCER
IF7.6
2024-01-315
OA
Gallagher, Emily J.; Moore, Heather; Lacouture, Mario E.; Dent, Susan F.; Farooki, Azeez; Goncalves, Marcus D.; Isaacs, Claudine; Johnston, Abigail; Juric, Dejan; Quandt, Zoe; Spring, Laura; Berman, Brian; Decker, Melanie; Hortobagyi, Gabriel N.; Kaffenberger, Benjamin H.; Kwong, Bernice Y.; Pluard, Timothy; Rao, Ruta; Schwartzberg, Lee; Broder, Michael S.
Invasive diseaseefree survival (iDFS) across key subgroups from the phase III NATALEE study of ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HRD/HER2-early breast cancer (EBC)
ANNALS OF ONCOLOGY
IF65.4
2023-10-013
PRE
Bardia, A.; Hortobagyi, G. N.; Lipatov, O.; McAndrew, N. P.; Lacko, A.; Sohn, J.; Hart, L.; Crown, J. P.; Im, S-A.; Harbeck, N.; O'Shaughnessy, J.; Xu, B.; Barrios, C. H.; Moroose, R.; Gonzalez, V.; Fresco, R.; Ghaznawi, F.; Waters, S.; Chakravartty, A.; Slamon, D.
Health-related quality of life (HRQoL) in the phase III NATALEE study of adjuvant ribociclib (RIB) plus a nonsteroidal aromatase inhibitor (NSAI) vs NSAI alone in patients (pts) with HRD/HER2-early breast cancer (EBC)
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Fasching, P. A.; Slamon, D.; Nowecki, Z.; Kukielka-Budny, B. D.; Stroyakovskiy, D.; Yardley, D.; Huang, C.; Chan, A.; Chia, S.; Martin, M.; Rugo, H. S.; Loi, S.; Hurvitz, S. A.; Untch, M.; Afenjar, K.; Fresco, R.; Danyliv, A.; Ferrusi, I.; Li, Z.; Hortobagyi, G. N.
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR+/HER2-early breast cancer

NATALEE的基本原理和试验设计: 在HR /HER2-early乳腺癌患者中，辅助ribociclib加内分泌治疗与单独内分泌治疗的III期试验

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-05-2940
OAAI
Slamon, Dennis J.; Fasching, Peter A.; Hurvitz, Sara; Chia, Stephen; Crown, John; Martin, Miguel; Barrios, Carlos H.; Bardia, Aditya; Im, Seock-Ah; Yardley, Denise A.; Untch, Michael; Huang, Chiun-Sheng; Stroyakovskiy, Daniil; Xu, Binghe; Moroose, Rebecca L.; Loi, Sherene; Visco, Frances; Bee-Munteanu, Valerie; Afenjar, Karen; Fresco, Rodrigo; Taran, Tetiana; Chakravartty, Arunava; Zarate, Juan Pablo; Lteif, Agnes; Hortobagyi, Gabriel N.
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy
INVESTIGATIONAL NEW DRUGS
IF2.7
2023-04-121
PRE
Abuhadra, Nour; Sun, Ryan; Bassett, Roland L.; Huo, Lei; Chang, Jeffrey T.; Teshome, Mediget; Clayborn, Alyson R.; White, Jason B.; Ravenberg, Elizabeth E.; Adrada, Beatriz E.; Candelaria, Rosalind P.; Yang, Wei; Ding, Qingqing; Symmans, W. Fraser; Arun, Banu; Damodaran, Senthil; Koenig, Kimberly B.; Layman, Rachel M.; Lim, Bora; Litton, Jennifer K.; Thompson, Alastair; Ueno, Naoto T.; Piwnica-Worms, Helen; Hortobagyi, Gabriel N.; Valero, Vicente; Tripathy, Debu; Rauch, Gaiane M.; Moulder, Stacy; Yam, Clinton
Patient-reported anxiety and fatigue in women enrolled in the RxPONDER trial (SWOG S1007) by menopausal status
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Loch, Michelle M.; Forschmiedt, Jamie K.; Kang, Irene M.; Gralow, Julie R.; Meric-Bernstam, Funda; Albain, Kathy S.; Hayes, Daniel F.; Lin, Nancy U.; Perez, Edith A.; Goldstein, Lori J.; Rastogi, Priya; Schott, Anne F.; Shak, Steven; Sharma, Priyanka; Lew, Danika L.; Miao, Jieling; Barlow, William E.; Tripathy, Debu; Pusztai, Lajos; Hortobagyi, Gabriel N.; Kalinsky, Kevin; Henry, N. Lynn
Race and clinical outcomes in the RxPONDER Trial (SWOG S1007)
CANCER RESEARCH
IF16.6
2023-03-016
PRE
Abdou, Yara; Barlow, William E.; Gralow, Julie R.; Meric-Bernstam, Funda; Albain, Kathy S.; Hayes, Daniel F.; Lin, Nancy U.; Perez, Edith A.; Goldstein, Lori J.; Chia, Stephen K.; Dhesy-Thind, Sukhbinder; Rastogi, Priya; Alba, Emilio; Delaloge, Suzette; Schott, Anne F.; Shak, Steven; Sharma, Priyanka; Lew, Danika L.; Miao, Jieling; Unger, Joseph M.; Tripathy, Debu; Pusztai, Lajos; Hortobagyi, Gabriel N.; Kalinsky, Kevin
Clinical and Molecular Characteristics of HER2-low/zero Early Stage Triple-Negative Breast Cancer
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Yam, Clinton; Li, Ziyi; Korkut, Anil; Ma, Wencai; Kong, Elisabeth; Hill, Holly A.; Abbas, Hussein; Abouharb, Sausan; Adrada, Beatriz; Arun, Banu K.; Barcenas, Carlos H.; Bisen, Ajit; Booser, Daniel; Buzdar, Aman; Candelaria, Rosalind; Chen, Junjie; Clayborn, Alyson; Damodaran, Senthil; Ding, Qingqing; Garber, Haven; Hortobagyi, Gabriel N.; Hunt, Kelly K.; Ibrahim, Nuhad K.; Iheme, Adaeze; Karuturi, Meghan S.; Koenig, Kimberly; Layman, Rachel M.; Lee, Jangsoon; Litton, Jennifer K.; Mitchell, Melissa; Moscol, Giancarlo; Mouabbi, Jason; Murthy, Rashmi K.; Oke, Oluchi; Pohlmann, Paula; Ramirez, David; Ravenberg, Elizabeth; Saleem, Sadia; Teshome, Mediget; Valero, Vicente; White, Jason; Williams, Madison; Woodward, Wendy; Yajima, Chasity; Ueno, Naoto T.; Chen, Ken; Rauch, Gaiane; Huo, Lei; Tripathy, Debu

研究方向

暂未获取到该数据
L
LiuMark
H 指数:114论文数:1,397被引数:6.8万
N
Naoto T. Ueno
H 指数:97论文数:1,425被引数:4.8万
A
Aman U. Buzdar
H 指数:115论文数:720被引数:5.3万
T
Thomas A. Buchholz
H 指数:108论文数:791被引数:4.3万
V
Vicente Valero
H 指数:118论文数:967被引数:4.8万
A
Ana M. González-Angulo
H 指数:101论文数:716被引数:3.7万
K
Kelly K. Hunt
H 指数:130论文数:1,407被引数:6.0万
F
Funda Meric‐Bernstam
H 指数:146论文数:2,622被引数:10.5万
A
Ayşegül A. Şahin
H 指数:105论文数:846被引数:4.2万
W
Wendy A. Woodward
H 指数:78论文数:891被引数:2.0万